| Patient | Mary Seacole |
|---|---|
| Date of birth | 1954-11-23 |
| Identifiers | MRN HR-NI027-SYN; SSN (made up) 000-27-4483 |
| Document date | 2026-09-14 |
| Author | Adwoa Fairweather-Kent, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Six-month review. [S]
Mary Seacole returns two months after her annual wellness visit and six months after her first visit. Her home readings average 126/74 on amlodipine and losartan, with no dizziness on standing and only slight evening ankle swelling. She has had no falls. She walks 20 minutes most days with her cane, goes to tai chi twice a week and to the lunch club, and has lost 2 kg. Her knee pain is 3 out of 10. Her bone density scan showed osteopenia (lowest T-score -1.7 at the left femoral neck) with a 10-year hip fracture risk of 1.4%, below the level at which medicine is advised. Her mammogram, stool test and hepatitis C test were normal. She would like her vaccines today. [S]
| Element | Detail |
|---|---|
| Home readings | Average 126/74 mmHg |
| Falls | None |
| Knees | Pain 3 out of 10; walking 20 minutes most days |
| Screening | Osteopenia below the treatment threshold; mammogram, stool test and hepatitis C normal |
| System | Result | Finding |
|---|---|---|
| Cardiovascular | Negative | No dizziness on standing, chest pain or breathlessness; slight evening ankle swelling |
| Neurological | Negative | No headaches, weakness or numbness |
| Musculoskeletal | Positive | Knee pain 3 out of 10; no muscle aches on atorvastatin |
3 systems reviewed. [S]
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Diclofenac sodium 1% topical gel, 4 g rubbed into each painful knee up to four times a day | 4 g to each knee up to four times a day | Topical route | 2026-03-09 | active | S |
| Amlodipine 5 mg oral tablet, one tablet daily | One tablet daily | Oral route | 2026-03-16 | active | S |
| Chlorthalidone 12.5 mg oral tablet, one tablet each morning | One tablet each morning | Oral route | 2026-03-16 to 2026-05-11 | completed | S |
| Atorvastatin 20 mg oral tablet, one tablet daily | One tablet daily | Oral route | 2026-04-13 | active | S |
| Losartan 25 mg oral tablet, one tablet daily | One tablet daily | Oral route | 2026-06-15 | active | S |
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 2026-09-14 | Body height | 157 | cm | S |
| 2026-09-14 | Body weight | 76 | kg | S |
| 2026-09-14 | Body mass index (BMI) [Ratio] | 30.8 | kg/m2 | S |
| 2026-09-14 | Systolic blood pressure | 128 | mm[Hg] | S |
| 2026-09-14 | Diastolic blood pressure | 76 | mm[Hg] | S |
| 2026-09-14 | Heart rate | 72 | /min | S |
| 2026-09-14 | Respiratory rate | 16 | /min | S |
| 2026-09-14 | Body temperature | 36.6 | Cel | S |
| 2026-09-14 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 | % | S |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 2026-09-14 | Pain severity - 0-10 verbal numeric rating [Score] - Reported | 3 | {score} | S | ||
| 2026-09-14 | Total interval score [KOOSJR] | 66.2 | {score} | S |
Vital signs recorded on 2026-09-14; see the Vital Signs section. [S]
| System | Finding |
|---|---|
| General | Well; blood pressure 128/76 seated, 126/74 standing at three minutes, pulse 72; weight 76.0 kg |
| Cardiovascular | Regular rhythm; trace ankle edema |
| Musculoskeletal | No knee effusion; Timed Up and Go 12 seconds |
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Headaches on waking for three weeks and blood pressure 184/102 mmHg at the visit (average of two seated readings with a large cuff); no chest pain, breathlessness, visual loss, confusion or weakness; fundi with arteriolar narrowing but no hemorrhages or papilledema; no hypertensive emergency; hypertension not yet confirmed | resolved | provisional | R03.0 | S — Synthetic presenting problem; resolved into stage 2 hypertension when a week of home readings confirmed it. Not a claim about her real health. |
| Stage 2 hypertension confirmed by home readings (seven-day average 168/96 mmHg), with left ventricular hypertrophy by ECG voltage; no albuminuria; 10-year cardiovascular risk about 14%; treated to reduce the risk of stroke, heart failure and kidney disease | active | confirmed | I10 | S — Synthetic modern diagnosis made at the second visit. It is linked to the recorded apoplexy before her death only as the reason for the stroke-prevention teaching; the record does not claim that she had hypertension. |
| Bilateral primary knee osteoarthritis, worse on the left: pain on stairs and on rising from a chair, morning stiffness under 30 minutes, crepitus and bony enlargement without warmth; clinical diagnosis without imaging | active | confirmed | M17.0 | S — Synthetic modern problem; not a claim about her real health. |
| Fall risk: one fall in the past year, a trip on the outside steps without injury; afraid of falling and going out less; STEADI screen positive; Timed Up and Go 15 seconds | active | confirmed | Z91.81 | S — Synthetic fall-risk problem. |
| Obesity, class 1 (BMI 31.6); she calls herself stout and wants to lose some weight for her knees | active | confirmed | E66.811 | S — Synthetic modern problem; her self-description as stout is documented, her weight is not. |
| Thiazide-associated hyponatremia (sodium 129 mmol/L) and hypokalemia (potassium 3.3 mmol/L) with orthostatic hypotension and a near-fall, after four days of a cold with little food while taking chlorthalidone; no confusion; resolved after chlorthalidone was stopped | resolved | confirmed | E87.1 | S — Synthetic adverse drug event at an unscheduled visit; a common effect of thiazide diuretics in older women, not a historical diagnosis. |
Protocol monitoring: items the monitoring protocol calls for at this visit. [S]
| Domain | Measure | Interval | Status | Detail |
|---|---|---|---|---|
| Examination | Blood pressure in the clinic (seated, large cuff, two readings) and at home; target below 130/80 mmHg | Every visit | Completed today | 128/76 mmHg; home average 126/74: at target |
| Examination | Orthostatic blood pressure (lying and standing) | Every visit | Completed today | No orthostatic drop |
| Examination | Weight and BMI (5% weight-loss goal for knee osteoarthritis) | Every visit | Completed today | 76.0 kg, BMI 30.8 (2.6% loss) |
| Examination | Cardiac auscultation and edema | Every visit | Completed today | Trace ankle edema |
| Laboratory | Sodium, potassium, creatinine and eGFR | Two to four weeks after starting or changing a diuretic or ARB; then every six months on these medicines | Up to date | Potassium 4.4 mmol/L and creatinine 0.98 mg/dL four weeks after losartan, at the wellness visit; next in six months |
| Laboratory | Lipid panel | Four to twelve weeks after starting a statin, then yearly | Up to date | LDL 82 mg/dL at the three-month review; next in a year |
| Laboratory | Urine albumin-to-creatinine ratio, hemoglobin A1c and TSH | At diagnosis, then yearly | Up to date | Normal six months ago; due in six months |
| Survey | Depression screen (PHQ-9) | Yearly | Up to date | PHQ-9 6 at the geriatric assessment; PHQ-2 1 at the wellness visit |
| Survey | Knee pain score (0 to 10) | Every visit | Completed today | 3 out of 10 |
| Survey | Knee function (KOOS JR) | Every visit | Completed today | KOOS JR 66.2 |
| Examination | Knee examination (range of motion, effusion, alignment, crepitus) | Every visit | Completed today | No effusion |
| Self-management | Exercise therapy, tai chi and self-management | Ongoing | Completed today | Tai chi twice a week; walks 20 minutes most days |
| Medication safety | NSAID safety (topical diclofenac; no oral NSAIDs) | Every visit | Completed today | Diclofenac gel only |
| Examination | STEADI assessment: Timed Up and Go, 30-second chair stand, 4-stage balance | At diagnosis of fall risk, then yearly or with a fall | Completed today | Timed Up and Go 12 seconds; no falls |
| Imaging | Bone density (DXA) and fracture risk | Women 65 and older; repeat by fracture risk | Completed today | Osteopenia, lowest T-score -1.7; 10-year hip fracture risk 1.4%, major osteoporotic fracture 8%: no medicine |
| Self-management | Her own remedies: interactions and how she uses them | Every visit | Completed today | Liquorice still paused; ginger tea and liniment |
| Self-management | Loneliness, costs and transport | Every visit | Completed today | Tai chi and lunch club; loneliness score improving; costs manageable |
| Self-management | Influenza and other vaccines | Yearly for influenza | Completed today | High-dose influenza vaccine, Tdap and zoster dose 2 today |
Goal progress:
Immunizations given today: Recombinant zoster vaccine, dose 2 of 2; Tetanus, diphtheria, and acellular pertussis vaccine (Tdap); Influenza vaccine, high-dose [S]
Guideline basis: 2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC/NMA/PCNA/SGIM Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults (2025); 2019 American College of Rheumatology/Arthritis Foundation Guideline for the Management of Osteoarthritis of the Hand, Hip, and Knee (2019); STEADI: Stopping Elderly Accidents, Deaths, and Injuries (2026); Falls Prevention in Community-Dwelling Older Adults: Interventions (2024); 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol (2018); Licorice Root (2026); Ginger (2026); CMID: Clinical Monitoring Intelligence Database, hypertension, osteoarthritis and osteoporosis monographs (2026); Osteoporosis to Prevent Fractures: Screening (2025); Adult Immunization Schedule by Age (2026)
Follow-up: Review in three months; metabolic panel and urine albumin in six months. COVID-19 vaccine this autumn. Call for any fall, dizziness or sudden weakness, numbness or trouble speaking (call 999 at once). [S]